Saltar al contenido
Merck

Cell cycle inertia underlies a bifurcation in cell fates after DNA damage.

Science advances (2021-02-02)
Jenny F Nathans, James A Cornwell, Marwa M Afifi, Debasish Paul, Steven D Cappell
RESUMEN

The G1-S checkpoint is thought to prevent cells with damaged DNA from entering S phase and replicating their DNA and efficiently arrests cells at the G1-S transition. Here, using time-lapse imaging and single-cell tracking, we instead find that DNA damage leads to highly variable and divergent fate outcomes. Contrary to the textbook model that cells arrest at the G1-S transition, cells triggering the DNA damage checkpoint in G1 phase route back to quiescence, and this cellular rerouting can be initiated at any point in G1 phase. Furthermore, we find that most of the cells receiving damage in G1 phase actually fail to arrest and proceed through the G1-S transition due to persistent cyclin-dependent kinase (CDK) activity in the interval between DNA damage and induction of the CDK inhibitor p21. These observations necessitate a revised model of DNA damage response in G1 phase and indicate that cells have a G1 checkpoint.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Toxina del cólera from Vibrio cholerae, ≥90% (SDS-PAGE), lyophilized powder
Sigma-Aldrich
Hydrocortisone, BioReagent, suitable for cell culture
Sigma-Aldrich
Anti-vinculina monoclonal antibody produced in mouse, clone hVIN-1, ascites fluid
Sigma-Aldrich
Insulina from bovine pancreas, γ-irradiated, BioXtra, suitable for cell culture, potency: ≥20 units/mg (USP units), lyophilized powder
Sigma-Aldrich
Neocarzinostatin from Streptomyces carzinostaticus, ≥90% (SDS-PAGE), ~0.5 mg/mL
Sigma-Aldrich
MEK1/2 Inhibitor III, PD0325901, InSolution, ≥95%
Sigma-Aldrich
Cdk1/2 Inhibitor III, The Cdk1/2 Inhibitor III, also referenced under CAS 443798-55-8, controls the biological activity of Cdk1/2. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.